Van Brussel JP - Search Results

1

Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer.

Van Brussel JP, Jan Van Steenbrugge G, Van Krimpen C, Bogdanowicz JF, Van Der Kwast TH, Schröder FH, Mickisch GH. Van Brussel JP, et al. Among authors: van krimpen c, van der kwast th. J Urol. 2001 Jan;165(1):130-5. doi: 10.1097/00005392-200101000-00032. J Urol. 2001. PMID: 11125381

2

Circumvention of multidrug resistance in genitourinary tumors.

van Brussel JP, Mickisch GH. van Brussel JP, et al. Int J Urol. 1998 Jan;5(1):1-15. doi: 10.1111/j.1442-2042.1998.tb00226.x. Int J Urol. 1998. PMID: 9535594 Free article. Review.

3

Prognostic factors in renal cell and bladder cancer.

Van Brussel JP, Mickisch GH. Van Brussel JP, et al. BJU Int. 1999 May;83(8):902-8; quiz 908-9. doi: 10.1046/j.1464-410x.1999.00120.x. BJU Int. 1999. PMID: 10368227 Review. No abstract available.

4

Prognostic factors in prostate and testis cancer.

Van Brussel JP, Mickisch GH. Van Brussel JP, et al. BJU Int. 1999 May;83(8):910-6; quiz 916-7. doi: 10.1046/j.1464-410x.1999.00056.x. BJU Int. 1999. PMID: 10368228 Review. No abstract available.

5

Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins.

van Brussel JP, van Steenbrugge GJ, Romijn JC, Schröder FH, Mickisch GH. van Brussel JP, et al. Among authors: van steenbrugge gj. Eur J Cancer. 1999 Apr;35(4):664-71. doi: 10.1016/s0959-8049(98)00435-3. Eur J Cancer. 1999. PMID: 10492644

6

A phase II study of temozolomide in hormone-refractory prostate cancer.

van Brussel JP, Busstra MB, Lang MS, Catsburg T, Schröder FH, Mickisch GH. van Brussel JP, et al. Cancer Chemother Pharmacol. 2000;45(6):509-12. doi: 10.1007/s002800051027. Cancer Chemother Pharmacol. 2000. PMID: 10854140 Clinical Trial.

7

Multidrug resistance in prostate cancer.

van Brussel JP, Mickisch GH. van Brussel JP, et al. Onkologie. 2003 Apr;26(2):175-81. doi: 10.1159/000071510. Onkologie. 2003. PMID: 12771527 Review.

8

Identification of multidrug resistance-associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine.

van Brussel JP, Oomen MA, Vossebeld PJ, Wiemer EA, Sonneveld P, Mickisch GH. van Brussel JP, et al. BJU Int. 2004 Jun;93(9):1333-8. doi: 10.1111/j.1464-410X.2004.04847.x. BJU Int. 2004. PMID: 15180633

9

Endovenous laser ablation versus conventional surgery in the treatment of small saphenous vein incompetence.

Roopram AD, Lind MY, Van Brussel JP, Terlouw-Punt LC, Birnie E, De Smet AA, Van Der Ham AC. Roopram AD, et al. Among authors: van der ham ac, van brussel jp. J Vasc Surg Venous Lymphat Disord. 2013 Oct;1(4):357-63. doi: 10.1016/j.jvsv.2013.05.005. Epub 2013 Sep 4. J Vasc Surg Venous Lymphat Disord. 2013. PMID: 26992756 Free article.

10

Cryo perforator surgery with a diamond dust-coated cryoprobe.

Klem TM, van der Ham A, van Brussel J, Wittens C. Klem TM, et al. Vasc Endovascular Surg. 2010 Aug;44(6):446-8. doi: 10.1177/1538574410372677. Epub 2010 Jun 10. Vasc Endovascular Surg. 2010. PMID: 20538731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters